Growth Metrics

Cellebrite DI (CLBT) Receivables - Other (2020 - 2025)

Cellebrite DI's Receivables - Other history spans 6 years, with the latest figure at $78.6 million for Q4 2025.

  • Quarterly Receivables - Other fell 3.41% to $78.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $78.6 million through Dec 2025, down 3.41% year-over-year, with the annual reading at $78.6 million for FY2025, 3.41% down from the prior year.
  • Receivables - Other came in at $78.6 million for Q4 2025, down from $81.3 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $89.2 million in Q4 2023 to a low of $72.3 million in Q4 2021.
  • The 5-year median for Receivables - Other is $81.3 million (2024), against an average of $80.6 million.
  • Year-over-year, Receivables - Other surged 113.13% in 2021 and then dropped 8.78% in 2024.
  • Cellebrite DI's Receivables - Other stood at $72.3 million in 2021, then rose by 12.83% to $81.5 million in 2022, then grew by 9.38% to $89.2 million in 2023, then fell by 8.78% to $81.3 million in 2024, then fell by 3.41% to $78.6 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Receivables - Other are $78.6 million (Q4 2025), $81.3 million (Q4 2024), and $89.2 million (Q4 2023).